Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: studies with macrophages and polymorphonuclear neutrophils.
about
Investigational antimicrobial agents of 2013.Newer antibacterials in therapy and clinical trialsContrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus.Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophilaNonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial functionReversing resistance: The next generation antibacterials.New antibiotic agents in the pipeline and how they can help overcome microbial resistance.The oxazolidinones: past, present, and future.Antibiotics in development targeting protein synthesis.Prospects for new antibiotics: a molecule-centered perspective.Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis.Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates.Transport of Azithromycin into Extravascular Space in RatsAn azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants.Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.A metal-metalloporphyrin framework based on an octatopic porphyrin ligand for chemical fixation of CO2 with aziridines.Cellular pharmacokinetics and intracellular activity of gepotidacin against Staphylococcus aureus with different resistance phenotypes in models of cultured phagocytic cells.Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill.
P2860
Q34375204-1C30AD20-A458-40DA-84E9-7A3BEB9386BFQ34488329-5E680B72-4896-41D1-9665-20BF8543820BQ34528916-901DDB27-A469-4792-95C8-E245C78CB7EDQ34618656-7149FF98-1937-4C00-A263-357C19C0AA43Q34922189-34C051C7-5C81-424C-A708-4265EA04E567Q35669688-A0E75056-3F05-4C11-ACD8-46BB7DE8CBB5Q36845895-28454CDB-01CC-4699-A30B-A8CE7CD79C7AQ37970719-648A59A3-7D29-409A-830A-29857C7AC087Q37970724-3BE8DFAD-7C21-4531-A6D3-2DEED330C63BQ38113689-906785A2-5CD3-4400-A5CE-C7E35117326AQ38283321-7E663444-4C0A-4314-B290-6F501AA9E2F6Q40071545-07C1EBF9-5141-4652-B5ED-8B0A7D5048DFQ40549971-20F350A6-F6B1-4165-A63F-D45D736A2EF8Q41789967-1E183B81-29B4-4211-81F4-63BC9367CB1AQ41969496-E3DA66AF-06DE-444B-A8D7-1033305D2CB7Q47230154-E48FD89E-0F8C-4D02-ACB6-54ED4D011CDDQ49874631-24542E6B-348D-4217-BB5B-677B9AFDFE90Q50035189-CEA6A136-0D40-4F6C-93E5-120C7BE33E83Q55547799-3BBD7B3C-903A-443C-BF6C-EA5BE3FF46F1
P2860
Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: studies with macrophages and polymorphonuclear neutrophils.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cellular pharmacokinetics of t ...... polymorphonuclear neutrophils.
@en
Cellular pharmacokinetics of t ...... polymorphonuclear neutrophils.
@nl
type
label
Cellular pharmacokinetics of t ...... polymorphonuclear neutrophils.
@en
Cellular pharmacokinetics of t ...... polymorphonuclear neutrophils.
@nl
prefLabel
Cellular pharmacokinetics of t ...... polymorphonuclear neutrophils.
@en
Cellular pharmacokinetics of t ...... polymorphonuclear neutrophils.
@nl
P2860
P356
P1476
Cellular pharmacokinetics of t ...... polymorphonuclear neutrophils
@en
P2093
Sandrine Lemaire
P2860
P304
P356
10.1128/AAC.01723-09
P407
P577
2010-04-12T00:00:00Z